Michael Bianchi
Oral and Maxillofacial Surgery · Bryn Mawr, PANPI 1285663534
Payments from drug & device makers
Across 29 payments — averaging $56.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Keystone Dental Inc.$764
- Nobel Biocare USA$478
- Salvin Dental Specialties, Inc.$112
- Kls-martin L.p.$91
- Geistlich Pharma, North America, Inc.$72
- Pacira Pharmaceuticals Incorporated$25
- plus $93 from 5 others
What the payments were for
- Food & beverage$86953%
- Education$17511%
- Gifts$996%
- Entertainment$49130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Keystone Dental Inc. | 7 | $764 |
| Nobel Biocare USA | 9 | $478 |
| Salvin Dental Specialties, Inc. | 2 | $112 |
| Kls-martin L.p. | 3 | $91 |
| Geistlich Pharma, North America, Inc. | 2 | $72 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Henry Schein, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $21 |
| Zimvie Inc. | 1 | $19 |
| Straumann USA LLC | 1 | $18 |
| Colgate Oral Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOBELACTIVE$119
How this compares
$1,634 in reported general payments places this provider in the 70th percentile of 369 oral and maxillofacial surgery providers in Pennsylvania.
See all oral and maxillofacial surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 24 | $289 |
| Amoxicillin | 99 | $279 |
| Ibuprofen | 93 | $231 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $187 |
| Chlorhexidine Gluconate | 26 | $133 |
| Azithromycin | 28 | $103 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 30 | $97 |
| Ondansetron OdtOndansetron | 16 | $26 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Bryn Mawr
- Mark OchsPittsburgh$449K
- Ankur JohriAllentown$98K
- Richard BauerWexford$95K
- Joseph LeonettiPaoli$88K
- Larry CunninghamPitsburgh$83K
- Neeraj PanchalPhiladelphia$73K
- Eric GranquistPhiladelphia$65K
- Michael HartmanMechanicsburg$50K
- Bernard CostelloPittsburgh$44K
- Thomas HelfstStroudsburg$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.